Skip to main content

Table 2 Prognostic risk model for endometrial cancer

From: A novel risk score system of immune genes associated with prognosis in endometrial cancer

NameCoefHR; 95% CIP value
HTR3E0.5131.67 (1.34–2.09)0.000
CBLC0.0151.02 (1.01–1.02)0.000
TNF0.0341.03 (1.01–1.05)0.000
PSMC40.0041.00 (1.00–1.01)0.003
TRAV300.1101.12 (1.04–1.20)0.004
PDIA3− 0.0041.00 (0.99–1.00)0.004
FGF80.0201.02 (1.01–1.03)0.006
PDGFRA0.0291.03 (1.01–1.05)0.010
ESRRA0.0481.05 (1.01–1.09)0.013
SBDS0.0161.02 (1.00–1.03)0.016
CRHR10.1621.18 (1.02–1.35)0.021
LTA− 0.8190.44 (0.21–0.93)0.031
NR2F10.0191.02 (1.00–1.04)0.032
TNFRSF18− 0.0280.97 (0.95–1.00)0.038
VIPR2− 1.2310.29 (0.08–1.09)0.068
LGR50.0071.01 (1.00–1.01)0.068
IL13RA20.0241.02 (1.00–1.05)0.071
PTN0.0051.01 (1.00–1.01)0.080
BACH2− 0.4010.67 (0.42–1.07)0.090
GHR0.8162.26 (0.86–5.96)0.099
ADCYAP1R1− 0.0470.95 (0.90–1.01)0.133
ORM1− 0.0270.97 (0.94–1.01)0.148
  1. Coef coefficients, HR hazards ratio, CI confidence interval